LDR Holding Corp (NASDAQ: LDRH) and Exactech (NASDAQ:EXAC) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, valuation, profitability, risk and dividends.

Volatility & Risk

LDR Holding Corp has a beta of 1.11, indicating that its stock price is 11% more volatile than the S&P 500. Comparatively, Exactech has a beta of 1.01, indicating that its stock price is 1% more volatile than the S&P 500.

Earnings & Valuation

This table compares LDR Holding Corp and Exactech’s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio EBITDA Earnings Per Share Price/Earnings Ratio
LDR Holding Corp N/A N/A N/A ($0.71) -52.08
Exactech $262.96 million 2.28 $43.51 million $0.04 1,046.51

Exactech has higher revenue and earnings than LDR Holding Corp. LDR Holding Corp is trading at a lower price-to-earnings ratio than Exactech, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of recent recommendations for LDR Holding Corp and Exactech, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LDR Holding Corp 0 0 0 0 N/A
Exactech 0 3 0 0 2.00

Exactech has a consensus target price of $42.00, suggesting a potential upside of 0.36%. Given Exactech’s higher possible upside, analysts clearly believe Exactech is more favorable than LDR Holding Corp.

Profitability

This table compares LDR Holding Corp and Exactech’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
LDR Holding Corp -18.02% -16.37% -13.65%
Exactech 0.30% 7.39% 5.98%

Insider and Institutional Ownership

65.0% of Exactech shares are held by institutional investors. 28.3% of Exactech shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Exactech beats LDR Holding Corp on 8 of the 9 factors compared between the two stocks.

About LDR Holding Corp

LDR Holding Corporation is a medical device company. The Company focuses on designing and commercializing surgical technologies for the treatment of patients suffering from spine disorders. The Company’s primary products are based on its VerteBRIDGE fusion and Mobi non-fusion platforms, both of which are designed for applications in the cervical and lumbar spine. The Company’s VerteBRIDGE products are designed around its plating technology that enables surgeons to implant VerteBRIDGE devices with direct visualization of the disc and to affix the devices to the vertebrae from inside the spinal disc space. The Company’s Mobi non-fusion platform is underlined by Mobi-C, a cervical disc replacement device with a mobile bearing core that is designed to replicate the natural anatomical movement of the spine by facilitating independent bending and twisting similar to a healthy disc. The Company’s traditional fusion products include Easyspine, MC+, ROI, ROI-T, SpineTune and C-Plate.

About Exactech

Exactech, Inc. develops, manufactures, markets, distributes and sells orthopedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians. The Company’s segments include knee, hip, biologics and spine, extremity and other products. Its other products segment includes miscellaneous sales categories, such as bone cement, instrument rental fees, shipping charges and other product lines. The Company distributes joint replacement systems, including knee, hip, spine and extremity implant systems, and biologic products and services and bone cement materials used in orthopedic surgery and dental procedures. The Exactech Knee System provides solutions for partial, primary and revision total knee arthroplasty. Its hip solutions address the continuum of hip arthroplasty. It manufactures and distributes various products and services designed for the healing and regeneration of bone and soft tissue, including products, which contain human allograft.

Receive News & Ratings for LDR Holding Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LDR Holding Corp and related companies with MarketBeat.com's FREE daily email newsletter.